Financhill
Buy
81

LEU Quote, Financials, Valuation and Earnings

Last price:
$286.13
Seasonality move :
10.9%
Day range:
$306.00 - $326.36
52-week range:
$49.40 - $464.25
Dividend yield:
0%
P/E ratio:
49.09x
P/S ratio:
12.91x
P/B ratio:
16.20x
Volume:
967.3K
Avg. volume:
898K
1-year change:
338.52%
Market cap:
$5.9B
Revenue:
$442M
EPS (TTM):
$6.58

Analysts' Opinion

  • Consensus Rating
    Centrus Energy Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of $291.91, Centrus Energy Corp. has an estimated downside of -9.62% from its current price of $322.97.
  • Price Target Upside
    According to analysts, the highest upside price target is $390.00 representing 20.75% upside increase from its current price of $322.97.

Fair Value

  • According to the consensus of 14 analysts, Centrus Energy Corp. has -9.62% downside to fair value with a price target of $291.91 per share.

LEU vs. S&P 500

  • Over the past 5 trading days, Centrus Energy Corp. has overperformed the S&P 500 by 29.56% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Centrus Energy Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Centrus Energy Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Centrus Energy Corp. reported revenues of $74.9M.

Earnings Growth

  • Centrus Energy Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Centrus Energy Corp. reported earnings per share of $0.19.
Enterprise value:
5.5B
EV / Invested capital:
--
Price / LTM sales:
12.91x
EV / EBIT:
65.99x
EV / Revenue:
12.03x
PEG ratio (5yr expected):
1.30x
EV / Free cash flow:
38.21x
Price / Operating cash flow:
41.01x
Enterprise value / EBITDA:
59.00x
Gross Profit (TTM):
$131M
Return On Assets:
8.69%
Net Income Margin (TTM):
25.04%
Return On Equity:
48.43%
Return On Invested Capital:
14.24%
Operating Margin:
-22.16%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $342.8M $394M $454.1M $57.7M $74.9M
Gross Profit $103.7M $90.2M $131M $6.5M -$6M
Operating Income $51.2M $39M $82.8M -$7.6M -$16.6M
EBITDA $58.9M $49.2M $92.6M -$4.9M -$15.1M
Diluted EPS $3.14 $4.78 $6.58 -$0.30 $0.19
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $277M $373.6M $415.9M $442M $2.1B
Total Assets $487.2M $618.2M $644.7M $591M $2.2B
Current Liabilities $335.2M $397.9M $337.3M $316.9M $626.2M
Total Liabilities $716.3M $718.5M $668.7M $514.6M $1.9B
Total Equity -$229.1M -$100.3M -$24M $76.4M $363.1M
Total Debt $107.9M $147.6M $170.4M $116.1M $1.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $40.8M -$9.1M $153.8M -$36.2M $10.1M
Cash From Investing -$1.2M -$3.9M -$10.8M -$1M -$4.4M
Cash From Financing $23.8M $23.5M $1.3B $4.4M $781.8M
Free Cash Flow $39.6M -$13M $143M -$37.2M $5.7M
LEU
Sector
Market Cap
$5.9B
$39.5M
Price % of 52-Week High
69.57%
70.27%
Dividend Yield
0%
0%
Shareholder Yield
-6.72%
0.03%
1-Year Price Total Return
338.52%
-5.56%
Beta (5-Year)
1.242
0.424
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $273.60
200-day SMA
Buy
Level $207.65
Bollinger Bands (100)
Buy
Level 213.98 - 342.24
Chaikin Money Flow
Sell
Level -56.1M
20-day SMA
Buy
Level $260.25
Relative Strength Index (RSI14)
Buy
Level 67.69
ADX Line
Buy
Level 17.03
Williams %R
Sell
Level -3.2023
50-day SMA
Buy
Level $278.95
MACD (12, 26)
Buy
Level 6.08
25-day Aroon Oscillator
Buy
Level 56
On Balance Volume
Neutral
Level 88.7M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (1.8247)
Sell
CA Score (Annual)
Level (-1.8827)
Sell
Beneish M-Score (Annual)
Level (-1.7392)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.7285)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Stock Forecast FAQ

In the current month, LEU has received 9 Buy ratings 5 Hold ratings, and 0 Sell ratings. The LEU average analyst price target in the past 3 months is $291.91.

  • Where Will Centrus Energy Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Centrus Energy Corp. share price will drop to $291.91 per share over the next 12 months.

  • What Do Analysts Say About Centrus Energy Corp.?

    Analysts are divided on their view about Centrus Energy Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Centrus Energy Corp. is a Sell and believe this share price will rise from its current level to $117.00.

  • What Is Centrus Energy Corp.'s Price Target?

    The price target for Centrus Energy Corp. over the next 1-year time period is forecast to be $291.91 according to 14 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is LEU A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Centrus Energy Corp. is a Buy. 9 of 14 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of LEU?

    You can purchase shares of Centrus Energy Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Centrus Energy Corp. shares.

  • What Is The Centrus Energy Corp. Share Price Today?

    Centrus Energy Corp. was last trading at $286.13 per share. This represents the most recent stock quote for Centrus Energy Corp.. Yesterday, Centrus Energy Corp. closed at $322.97 per share.

  • How To Buy Centrus Energy Corp. Stock Online?

    In order to purchase Centrus Energy Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock